Immunologists are at the core of understanding how the body defends itself against disease, providing essential insights that guide the development of vaccines, treatments, and diagnostics. By studying the immune system’s responses to pathogens, allergens, and even the body’s own cells, they help uncover mechanisms that can be targeted to prevent or treat illness. Their work spans both laboratory and clinical settings, where they explore cellular behavior, antibody production, and immune memory to advance medical science. Immunologists are crucial in identifying immune deficiencies, autoimmune conditions, and inflammatory disorders, which directly contributes to improving patient outcomes and quality of life.
In the field of infectious disease control, immunologists play a vital role by guiding how immune responses can be harnessed to combat viruses, bacteria, and other threats. Their research often lays the foundation for vaccine development and effectiveness testing, ensuring that immunization strategies are backed by robust scientific evidence. They collaborate with public health professionals, researchers, and biotechnologists to translate findings into practical health solutions. As new health threats emerge, immunologists continue to adapt and innovate, using cutting-edge technologies like immunogenomics and systems biology. Their contributions not only advance therapeutic science but also enhance global health resilience, making their work indispensable in both prevention and treatment strategies worldwide.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States